Form 8-K ATOSSA GENETICS INC For: Nov 12
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
Atossa Genetics (ATOS) Reports Q3 Loss of $0.15/Share
November 12, 2015 4:05 PM ESTAtossa Genetics (NASDAQ: ATOS) reported Q3 EPS of ($0.15), versus ($0.13) reported last year. Revenue for the quarter came in at $772.2 thousand, versus $3.4 thousand reported last year.
Announced today that the National Cancer Institute, Division of Cancer Prevention, has approved a Letter of... More
